We excel and make breakthroughs in and across science, art, technology and business. We renew our society with research-based knowledge, creativity and entrepreneurial mindset. Aalto University has been ranked the 7th best young university in the world (Top 50 under 50, QS 2018) and one of the world’s top technology challenger universities (THE 2017), thinking outside the box on research collaboration, funding and innovation. Aalto has six schools with 20 000 students and 5 000 employees of which close to 450 are professors. Our campus is located in Espoo, Finland. With over 50% of our academic faculty coming from outside Finland, we are a highly international community with strong academic standing. At Aalto, high-quality research, art, education and entrepreneurship are promoted hand in hand. Disciplinary excellence is combined with multidisciplinary activities, engaging both students and the local innovation ecosystem. Our main campus is quickly transforming into an open collaboration hub that encourages encounters between students, researchers, industry, startups and other partners. With an exceptionally strong entrepreneurial community, 70-100 new companies are born in our ecosystem every year. Aalto University was founded in 2010 as three leading Finnish universities, Helsinki University of Technology, the Helsinki School of Economics and the University of Art and Design Helsinki, were merged to strengthen Finland’s innovative capability.

With Adon Health, we pursue the vision of transforming the European healthcare landscape by enabling innovative, data-driven and personalised treatment paths for hormonal disorders in men under medical supervision. Our current objective is simplifying access to and treatment of testosterone deficiencies, we therefore offer: 1. At-home laboratory test kits for testosterone level measurement 2. Telemedical consultation with independent specialists 3. Treatment and post-treatment care and patient support We believe that every man has the right to a fulfilling and healthy life. That's why, with our cutting-edge technology and network of leading experts, we are creating a future where treating hormonal imbalances is no longer a taboo subject, but an integral part of men's health.

Elixion is a next generation HealthTech company. Our AI & IoT platform helps hospitals predict healing, prevent complications, and automate nursing care.

BRYCK is the new innovation hub and future factory at the heart of the Ruhr area. BRYCK creates a space for aspiring founders, growing startups, progressive scientists, accelerating VCs, corporate innovators and supportive startup hubs, networks and acceleration-programs.   However, BRYCK is more than just a space to work in: we are building a community of people with  passion, with expertise, with visions and ideas. We want to amplify what's already successful and co-create what's still needed. Collaboration is the heart of our mission. Be part of it. Be part of BRYCK. Let's build a livable future together. https://bryck.com/ Imprint: bryck.com/imprint Privacy: bryck.com/privacy

TRIGA-S is a specialised Contract Research Organisation (CRO) with over 25 years of experience in analytical and clinical performance studies for in vitro diagnostics (IVDs) and companion diagnostics (CDx). As an ISO 13485-certified CRO with our own in-house BSL-2 laboratory, we support IVD manufacturers with conformity assessment under the IVDR – and pharmaceutical companies from exploratory R&D analytics through to CDx validation. We deliver robust evidence for market access and keep your IVDR conformity and CDx milestones on track. Our modular service portfolio covers the full study lifecycle: - Study Management & Monitoring - Biostatistics & Evidence - Sample Management - Contract Analytical Testing & Applications - Clinical Study Supply Management All services can be booked individually, in combination, or as an end-to-end solution. Ready to discuss your project? Book a meeting with us: https://bookings.cloud.microsoft/book/TRIGASGmbHConsultancy@triga-s.de/s/Gm1b5qTEcEWb5rlSoa-nKw2?ismsaljsauthenabled

H2YO great-tasting healthy infusions that enable workplaces to offer choices that drive healthy habits. We make a low cost small foot-print dispenser, supply ingredient cartridges, and provide an IT-enabled platform that seamlessly connects dispensing devices, users, and companies enabling a drinks as a service model and personalization of drinks.

Wellness is the new front door to healthcare. Consumers don’t want to know what’s possible. They want to know what works and what to prioritize, with clinical-grade proof. We help business partners meet that demand with technology made for the moment: A configurable health intelligence layer that democratizes access to the same proven, hyper-personalized, biology-based insights that made us a D2C leader. Built on over a decade of direct-to-consumer leadership and years of deep enterprise experience, our new platform is purposefully designed for companies reshaping consumer wellness. Powered by a sophisticated AI engine, InsideTracker technology helps businesses turn blood, physio, wearable, DNA, and partner data into precise, individualized health guidance — using logic validated by a peer-reviewed, 20,000-user study showing sustained improvement across 43 biomarkers. It’s the interoperable infrastructure businesses need to move from transactional interactions to sustained customer engagement. And it’s where wellTech leaders can unlock the clinical credibility and operational efficiency they need to deliver scientifically proven health benefits at scale.

Aktiia, now trading under Hilo, was established in 2018 to transform how blood pressure is measured and therefore managed. Hilo is transforming blood pressure monitoring with cuffless, AI-powered technology that delivers continuous, accessible insights for individuals and healthcare professionals. Our foundation model is trained on billions of optical signals and hundreds of millions of readings from over 120,000 users—one of the largest datasets in the field. Backed by a multidisciplinary team with deep expertise in biomedical signal processing, Hilo has contributed to over 120 peer-reviewed publications and holds more than 35 patents. Headquartered in Switzerland, we’re expanding globally to redefine how blood pressure is measured and managed.

At Quibim, we design pioneering tools that unlock imaging data to improve patient outcomes. Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers.

We provide finance and expertise for sustainable investment projects that contribute to EU policy objectives and make a strong impact on people’s lives in Europe and beyond. The EU's bank The EIB is the European Union's bank. We are the only bank owned by and representing the interests of the European Union Member States. We work closely with other EU institutions to implement EU policy. A major player As the largest multilateral borrower and lender by volume, we provide finance and expertise for sound and sustainable investment projects which contribute to furthering EU policy objectives. More than 90% of our activity is focused on Europe but we also implement the financial aspects of the EU's external and development policies. Lending, blending and advising Lending: The vast majority of our financing is through loans, but we also offer guarantees, microfinance, equity investment, etc. Blending: Our support helps us unlock financing from other sources, particularly from the EU budget. This is blended together to form the full financing package. Advising: Lack of finance is often only one barrier to investment. We can help with administrative and project management capacity which facilitates investment implementation.

THE HIGHWAY FOR ONCOLOGIC SOLUTIONS We are the digital solution based on AI, transforming care delivery by democratizing access to screening & diagnosis while providing an efficient path to treatment. Solución digital basada en IA, que transforma el sistema de salud democratizando el acceso a la detección y diagnóstico mientras brinda un camino eficiente al tratamiento.

Plug and Play is a global innovation platform founded in Silicon Valley in 2006. We connect the people and organizations that drive technology forward, and turn those connections into real business outcomes. We run accelerator programs, facilitate corporate-startup pilots, invest in early-stage companies, and help governments and institutions build innovation ecosystems. Our network includes corporations, startups, investors, universities, and mentors across more than 20 industries and 60 locations worldwide. Since inception, we've accelerated thousands of startups and invested in over 2,500 companies. Our portfolio includes PayPal, Dropbox, LendingClub, Honey, and N26. Industries we work in: Advanced Manufacturing · Aerospace & Defense · Agtech · Animal Health · Brand & Retail · Crypto & Digital Assets · Deeptech · Energy · Enterprise & AI · Fintech · Food & Beverage · Health · Insurtech · Lifetech · Maritime · Media & Advertising · Medtech · Mobility & Physical AI · New Materials & Packaging · Real Estate & Construction · Semiconductors · Smart Cities · Sportstech · Supply Chain · Sustainability · Travel & Hospitality Where we operate: Americas: Silicon Valley · New York · Los Angeles · Washington D.C. · Detroit · Seattle · São Paulo · Alberta Europe: London · Munich · Stuttgart · Paris · Amsterdam · Barcelona · Madrid · Milan · Turin · Gothenburg · Vienna · Istanbul · Antwerp · Vilnius · Tirana · Yerevan · Tbilisi · Limassol · Tashkent Middle East & Africa: Riyadh · Abu Dhabi · Cairo Asia-Pacific: Tokyo · Osaka · Kyoto · Singapore · Seoul · Shanghai · Beijing · Shenzhen · Jakarta · Kuala Lumpur · Phnom Penh · GIFT City

CBRE are committed to responsible and sustainable business practices. They believe sustainable success can only be built on a foundation of responsible business practices, and that everyone gains an advantage by subscribing to the values of RISE (Respect, Integrity, Service and Excellence). As the world’s largest commercial real estate services firm, The recognize the impact we have on our communities, clients, employees and stakeholders, corporate responsibility are key to providing industry leadership that grows our business in socially responsible ways.

Transforming rehabilitation and prevention through the power of AI. At DyCare, we cover the full cycle of physical health — from prevention to recovery — through an AI-powered digital health platform with motion analysis technology that is 4 times more accurate than human observation. Because delivering truly high-quality therapeutic care demands more than the human eye alone can offer. Our flagship rehabilitation platform tracks over 60 key body points in real time, allowing clinicians to prescribe fully personalized therapy programs and monitor patient progress remotely with clinical precision. Patients are guided through their exercises with real-time corrections, ensuring every movement is performed safely and effectively — from the comfort of their own home. With over 3 million treatments delivered, we're helping healthcare providers scale clinical excellence — efficiently and without compromise. Certified as a Class IIa medical device and backed by 4 clinical studies and over 25 scientific communications, DyCare is built on the highest standards of clinical evidence, safety, and trust. This isn't just technology — it's science you can prescribe with confidence. And we're just getting started. In 2025, we launched our new Prevention product — bringing AI-driven movement intelligence into everyday life to help people recover faster, move better, and build long-term physical resilience. Because sustainable health isn't just about treating injury — it's about empowering people to stay active and strong every single day. Two products. One mission: making people healthier, at every stage of life Learn more at www.dycare.com

Siemens Healthineers is a leading medtech company with over 125 years of experience. We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Our portfolio, spanning in vitro and in vivo diagnostics to image-guided therapy and cancer care, is crucial for clinical decision-making and treatment pathways. With our strengths in patient twinning, precision therapy, as well as digital, data, and artificial intelligence (AI), we are well positioned to take on the greatest challenges in healthcare. We will continue to build on these strengths to help overcome the world’s most threatening diseases, enable efficient operations, and expand access to care. We are a team of more than 71,000 Healthineers in over 70 countries passionately pushing the boundaries of what is possible in healthcare to help improve the lives of people around the world.

Vital Signs Technologies (VST) has more than 75 years of combined experience in patient monitoring. The three founders of our company have been a part of many changes and advancements in our industry beginning with the introduction of noninvasive pulse oximetry. They built their businesses by treating customers as friends, offering products that were the best value for their money and support that minimized downtime. In recent years, there has been a widening gap between quality and price. Policies that support customers have been abandoned in favor of shareholder profits. Meeting customer expectations had become difficult not only in price, but in reliability and after the sale support. We evaluated products from many different manufacturers, and found them all lacking in at least one of our criteria. The monitors that bear our name are proven for their reliability and performance. VST monitors have capabilities that surpass any expectations while being cost effective. If a product should require service, it will be performed quickly and efficiently. During this process you will be provided with a service loaner free of charge.

Vital Signs Technologies (VST) has more than 75 years of combined experience in patient monitoring. The three founders of our company have been a part of many changes and advancements in our industry beginning with the introduction of noninvasive pulse oximetry. They built their businesses by treating customers as friends, offering products that were the best value for their money and support that minimized downtime. In recent years, there has been a widening gap between quality and price. Policies that support customers have been abandoned in favor of shareholder profits. Meeting customer expectations had become difficult not only in price, but in reliability and after the sale support. We evaluated products from many different manufacturers, and found them all lacking in at least one of our criteria. The monitors that bear our name are proven for their reliability and performance. VST monitors have capabilities that surpass any expectations while being cost effective. If a product should require service, it will be performed quickly and efficiently. During this process you will be provided with a service loaner free of charge.

With approximately 1.7 million insured persons, approximately 31'100 corporate clients and a premium volume of 5,8 billion francs, SWICA Healthcare Organisation is one of Switzerland's leading health and accident insurers. Its product offering is available to both private individuals and companies and provides comprehensive insurance cover for medical expenses and loss of earnings due to illness and accident. SWICA is a health partner with a focus on above-average service quality and a high-quality service offering. SWICA has its headquarters in Winterthur and operates across Switzerland.

ISARTAL HEALTH MEDIA – Ein Schwesterunternehmen der Wort und Bild Verlagsgruppe COMPANY - Unternehmensaufbau, Firmenbeteiligung und Beratung PRODUCT - Digitale Produkt- und Software-Entwicklung CONTENT - Fachjournalismus, Kommunikation und Design WIR GESTALTEN GESUNDHEIT Bei der Isartal Health Media verstehen wir die Herausforderungen der Gesundheitsbranche. Deshalb bieten wir maßgeschneiderte Lösungen, die genau auf Ihre Bedürfnisse zugeschnitten sind: von Company Building über Produktentwicklung bis hin zu zielgerichtetem Media-Content – wir sind Ihr All-in-One-Partner. Unser Ziel ist Ihr Erfolg in einer sich rasant entwickelnden Branche. Profitieren Sie von unserer Leidenschaft, unserer Erfahrung und unserem Netzwerk. Wir sind nur eine Mail entfernt: info@ih.media

Die Isartal Ventures GmbH & Co. KG ist die Beteiligungsgesellschaft der Wort & Bild-Verlagsgruppe für frühphasige Direktinvestments. Wir unterstützen mit Know-how, Netzwerk und Kapital Startups mit E-Health-Fokus. Als mittelständische Beteiligungsgesellschaft ist es unser Ziel junge Unternehmen im deutschsprachigen Raum zu unterstützen - in Form von Direktinvestments, Joint-Venture-Beteiligungen, Digital-Health-Fonds, Media4Equity, Media4Revenue, Netzwerk- und Branchen-Know-How. Unser Fokus liegt auf Geschäftsideen und Ertragsmodellen im Gesundheitsbereich, die die Apotheke vor Ort stärken. Wir kooperieren unter anderem mit der Dieter von Holtzbrinck Ventures und Noventi, einem der führenden Technologie-Anbieter im Gesundheitsmarkt. Isartal Ventures ist Teil der Wort & Bild-Verlagsgruppe. Hier ist man seit über sechs Jahrzehnten spezialisiert auf die Kommunikation von Gesundheitsthemen. Und bekannt für seine Medien, darunter Deutschlands Gesundheitsmagazin Nummer 1, die Apotheken Umschau. Impressum und Datenschutz: https://www.isartal-ventures.de/

Die Isartal Ventures GmbH & Co. KG ist die Beteiligungsgesellschaft der Wort & Bild-Verlagsgruppe für frühphasige Direktinvestments. Wir unterstützen mit Know-how, Netzwerk und Kapital Startups mit E-Health-Fokus. Als mittelständische Beteiligungsgesellschaft ist es unser Ziel junge Unternehmen im deutschsprachigen Raum zu unterstützen - in Form von Direktinvestments, Joint-Venture-Beteiligungen, Digital-Health-Fonds, Media4Equity, Media4Revenue, Netzwerk- und Branchen-Know-How. Unser Fokus liegt auf Geschäftsideen und Ertragsmodellen im Gesundheitsbereich, die die Apotheke vor Ort stärken. Wir kooperieren unter anderem mit der Dieter von Holtzbrinck Ventures und Noventi, einem der führenden Technologie-Anbieter im Gesundheitsmarkt. Isartal Ventures ist Teil der Wort & Bild-Verlagsgruppe. Hier ist man seit über sechs Jahrzehnten spezialisiert auf die Kommunikation von Gesundheitsthemen. Und bekannt für seine Medien, darunter Deutschlands Gesundheitsmagazin Nummer 1, die Apotheken Umschau. Impressum und Datenschutz: https://www.isartal-ventures.de/

Health Tech Forward returns on December 3-4, 2025, in Barcelona, Spain. Join 1000+ digital health entrepreneurs, medical experts, VCs, and policymakers as they explore the latest trends and accelerate new partnerships.

Shen AI transforms digital health services with advanced AI Health Monitoring. Our SDK enables seamless integration of accessible, AI-powered health checks into existing apps and platforms, delivering accurate vital signs measurements in 30 seconds. Unlike physical devices, Shen AI provides a scalable, efficient solution that empowers healthcare providers and insurers to enhance care and reduce costs. Shen AI's smartphone-based face scan takes just 30 seconds and provides vital signs readings such as: ☑️ Blood Pressure ☑️ Heart Rate ☑️ Heart Rate Variability (HRV) ☑️ Respiratory Rate ...and many other. Measurements can be done on any smartphone, tablets, or laptop equipped with a camera. Shen AI also provides a number of health indices, such as: Stress Index, Vascular Age, Cardiac Workload, and CVDs Risks.

PIPRA AG is a Swiss digital health innovator addressing neurocognitive diseases, beginning with a focus on a critical and vastly underserved healthcare challenge: Delirium. Delirium impacts 1 in 4 hospital patients over 60, dramatically increasing dementia risk by 14x and nursing home admissions by 6x. Despite costing healthcare systems 60% more than diabetes, delirium remains poorly managed and underrecognized.   PIPRA’s CE-certified, AI-driven solution provides hospitals with rapid, accurate, and cost-effective tools for delirium risk management already validated and in use across leading healthcare facilities in E.U. and U.S. Our technology enables hospitals to implement targeted preventive interventions, significantly improving patient outcomes, shortening hospital stays, and achieving avg savings of €2.5 million per 1,000 patients, demonstrated in peer-reviewed publications including "Age and Ageing", “BMJ” and "JAMA Network Open."   With prestigious international awards, strategic global partnerships, and a clearly defined roadmap to scale, PIPRA is uniquely positioned to become the global market leader in delirium management.

The Cigna Group is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions, and has more than 190 million customer relationships around the world.